Tulavi Therapeutics Patents – Insights & Stats (Updated 2023)

Tulavi Therapeutics has a total of 40 patents globally, out of which 5 have been granted. Of these 40 patents, more than 92% patents are active. The United States of America is where Tulavi Therapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Tulavi Therapeutics.

Tulavi Therapeutics was founded in 2018. Tulavi Therapeutics is a biotechnology company that is dedicated to creating novel treatments for disorders mediated by the nervous system. The company’s approach is focused on creating treatments that go straight after the nerves in order to prevent and/or cure abnormal neural reflex arcs associated with peripheral and visceral diseases.

Do read about some of the most popular patents of Tulavi Therapeutics which have been covered by us in this article and also you can find Tulavi Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tulavi Therapeutics patent portfolio.

How many patents does Tulavi Therapeutics have?

Tulavi Therapeutics has a total of 40 patents globally. These patents belong to 6 unique patent families. Out of 40 patents, 37 patents are active.

How Many Patents did Tulavi Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantTulavi Therapeutics Applications FiledTulavi Therapeutics Patents Granted
202321
202262
2021111
20201
201912
20181
20177
20161

How many Tulavi Therapeutics patents are Alive/Dead?

Worldwide Patents

How Many Patents did Tulavi Therapeutics File in Different Countries?

Countries in which Tulavi Therapeutics Filed Patents

CountryPatents
United States Of America15
Australia6
Canada5
Europe4
China4
Hong Kong (S.A.R.)2

Where are Research Centers of Tulavi Therapeutics Patents Located?

The Research Centers of TulaviTherapeuticsPatents is the United States of America.

10 Best Tulavi Therapeutics Patents

US9855317B2 is the most popular patent in the Tulavi Therapeutics portfolio. It has received 229 citations so far from companies like Cardionomic, and Cilag.

Below is the list of 10 most cited patents of Tulavi Therapeutics:

Publication NumberCitation Count
US9855317B236
US20180147260A112
WO2019178564A110
US20210187160A14
US20210268271A13
CN112118828A3
US20210205501A12
CN110035754A2
CA3093923A12
WO2021146330A12

What Percentage of Tulavi Therapeutics US Patent Applications Were Granted?

Tulavi Therapeutics (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100%.

Below are the key stats of Tulavi Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Tulavi Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Knobbe Martens Olson & Bear Llp14100%

List of Tulavi Therapeutics patents

Tulavi Therapeutics PatentsTitle
US11446359B2Systems And Methods For Cardiac Plexus Neuromodulation
US11246879B2Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nerves
US11154547B2Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System
US9855317B2Systems And Methods For Sympathetic Cardiopulmonary Neuromodulation
US20220409902A1Methods And Devices For Nerve Regeneration
US20220370345A1Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nerves
US20220280497A1Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System
US20220096711A1Method Of Facilitating Nerve Growth
US20220054705A1Devices For In Situ Formed Nerve Caps And/Or Nerve Wraps
US20210361292A1Methods For In Situ Formed Nerve Cap With Rapid Release
US20210315587A1Methods And Devices For In Situ Formed Nerve Cap With Rapid Release
US20210268271A1Systems And Methods For Visceral Neuromodulation
US20210205501A1Systems And Methods For Gel-Based Neuromodulation
US20210187160A1Methods And Devices For In Situ Formed Nerve Cap
US20180147260A1Systems And Methods For Sympathetic Cardiopulmonary Neuromodulation
EP4090261A1Methods And Devices For In Situ Formed Nerve Cap With Rapid Release
EP3817786A4Methods And Devices For In Situ Formed Nerve Cap
EP3764990A4Systems And Methods For Gel-Based Neuromodulation
EP3478287A4Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System
CN115361912AMethods And Devices For In-Situ Formation Of Nerve Caps With Quick Release
CN112638437AMethods And Devices For In Situ Formed Nerve Cap
CN112118828ASystems And Methods For Gel-Based Neuromodulation
CN110035754ATreatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System
WO2023288218A1Methods And Devices For Nerve Regeneration
AU2017290353B2Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System
AU2022252296A1Methods And Compositions For The Ablation Of Nerves
AU2023214230A1Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System
AU2021207853A1Methods And Devices For In Situ Formed Nerve Cap With Rapid Release
AU2019299519A1Methods And Devices For In Situ Formed Nerve Cap
AU2019236300A1Systems And Methods For Gel-Based Neuromodulation
CA3210288A1Methods And Compositions For The Ablation Of Nerves
CA3163429A1Methods And Devices For In Situ Formed Nerve Cap With Rapid Release
CA3105343A1Methods And Devices For In Situ Formed Nerve Cap
CA3093923A1Systems And Methods For Gel-Based Neuromodulation
CA3031761A1Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System
HK40082864AMethods And Devices For In Situ Formed Nerve Cap With Rapid Release
HK40049073AMethods And Devices For In Situ Formed Nerve Cap
WO2022212562A1Methods And Compositions For The Ablation Of Nerves
WO2021146330A1Methods And Devices For In Situ Formed Nerve Cap With Rapid Release
WO2019178564A1Systems And Methods For Gel-Based Neuromodulation

What are Tulavi Therapeutics key innovation segments?

What Technologies are Covered by Tulavi Therapeutics?

The chart below distributes patents filed by Tulavi Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Tulavi Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Tulavi Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Tulavi Therapeutics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.